Effect of bucladesine sodium on the plasma concentrations and urinary excretion of purine bases and uridine

Metabolism: Clinical and Experimental

Volumn 47, Issue 8, 1998, Pages 1005-1008

  Yamamoto, Tetsuya ^a   Moriwaki, Yuji ^a   Takahashi, Sumio ^a   Tsutsumi, Zenta ^a   Ohata, Hiroyuki ^a   Fujita, Touru ^a   Yamakita, Jun Ichi ^a   Nakano, Takashi ^a   Hiroishi, Keisai ^a   Higashino, Kazuya ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; CHLORIDE; GLUCAGON; GLUCOSE; HYPOXANTHINE; INSULIN; PHOSPHATE; PURINE; SODIUM; URIC ACID; URIDINE; XANTHINE;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PURINE METABOLISM; URINARY EXCRETION;

EID: 13144307076     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90359-6     Document Type: Article

References (26)

1. Imai S, Otorii T, Takeda K, et al: Effects of cyclic AMP and dibutyryl cyclic AMP on the heart and coronary circulation. Jap J Pharmacol 24:499-510, 1974
2. Nozaki H, Okuaki A: Responses to exogenous dibutyryl adenosine 3', 5' -monophosphate of cardiac output and blood flow in the renal, superior mesenteric and carotid arteries in anesthetized dogs. Tohoku J Exp Med 115:145-154, 1975
3. Miyagi Y, Sasayama S, Nakajima H, et al: Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure. J Cardiovasc Pharmacol 15:138-143, 1990
4. Suemori I: Experimental study of dibutyric cyclic AMP; its metabolic effects observed in anesthetized human subjects. Tohoku J Exp Med 117:111-118, 1975
5. Suemori I, Yoshitake J: Experimental study of bibutyryl cyclic AMP: Its antishock effects observed in traumatic shock. Tohoku J Exp Med 119:123-133, 1976
6. Yoshida A, Nishikawa T, Tamura Y, et al: ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells. 266:4288-4294, 1991
7. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of glucagon on the xylitol-induced increase in the plasma concentration and urinary excretion of purine bases. Metabolism 45:1354-1359, 1996
8. Role TF, Kognut MD: The pathogenesis of hyperuricemia in glycogen storage disease, type I. Pediatr Res 11:664-669, 1977
9. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of glucagon on renal excretion of oxypurinol and purine bases. J Rheumatol 24:708-713, 1997
10. Ahloulay M, Dechaux M, Laborde K, et al: Influence of glucagon on GFR and urea and electrolyte excretion: Direct and indirect effects. Am J Physiol 269:F225-F235, 1995
11. Ahloulay M, Dechaux M, Hassler C, et al: Cyclic AMP is a hepatorenal link influencing natriuresis and contributing to glucagon-induced hyperinfiltration in rats. J Clin Invest 98:2251-2258, 1996
12. Bankir L, Martin H, Dechaux M, et al: Plasma cAMP: A hepatorenal link influencing proximal reabsorption and renal hemodynamics? Kidney Int 59:850-56, 1997 (suppl)
13. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of amino acids on the excretion of purine bases and oxypurinol. Nephron 73:41-47, 1996
14. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effects of probenecid, benzbromarone and pyrazinamide. Nephron 48:116-120, 1988
15. Auscher C, Pasquier C, Pehuet P, et al: Study of urinary pyrazinamide metabolites and their action on the renal excretion of xanthine and hypoxanthine in a xanthinuric patient. Biomedicine 28:129-133, 1978
16. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of glucagon on renal excretion of oxypurinol and purine bases. J Rheumatol 24:708-713, 1997
17. Gomez-Angelats M, Santo BD, Mercader J, et al: Hormonal regulation of concentrative nucleoside transport in liver parenchymal cells. Biochem J 313:915-920, 1996
18. Yamamoto T, Moriwaki Y, Takahashi S, et al: Separation of hypoxanthine and xanthine from pyrazinamide and its metabolites in plasma and urine by high-performance liquid chromatography. J Chromatogr 382:270-274, 1986
19. Smolenski RT, de Jong JW, Janssen M, et al: Formation and breakdown of uridine in ischemic heart of rats and humans. J Mol Cell Cardiol 25:67-74, 1993
20. Swain JL, Sabina RL, McHale PA, et al: Prolonged myocardial nucleotide depletion after brief ischemia in the open-chest dog. Am J Physiol 242:H818-H826, 1982
21. Harkness RA: Hypoxanthine, xanthine and uridine in body fluids, indicators of ATP-depletion. J Chromatogr 249:255-278, 1988
22. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of ethanol and fructose on plasma uridine and purine bases. Metabolism 46:544-547, 1997
23. Yamamoto T, Moriwaki Y, Takahashi S, et al: Xylitol-induced increase in the plasma concentration and urinary excretion of uridine and purine bases. Metabolism 47:739-743, 1998
24. Yamamoto T, Moriwaki Y, Takahashi S, et al: Effect of muscular exercise on the concentration of uridine and purine bases in plasma - ATP consumption- induced pyrimidine degradation. Metabolism 46: 1339-1342, 1997
25. Che M, Nishida T, Gatmaitan Z, et al: A nucleoside transporter is functionally linked to ectonucleotidases in rat liver canalicular membrane. J Biol Chem 267:9684-9688, 1992
26. +-dependent uridine uptake in the regenerating rat liver. FEBS Lett 316:85-88, 1993